Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.
Molecular Genetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, ON N6A 5W9, Canada.
Int J Mol Sci. 2021 Jan 23;22(3):1111. doi: 10.3390/ijms22031111.
A growing number of genetic neurodevelopmental disorders are known to be associated with unique genomic DNA methylation patterns, called episignatures, which are detectable in peripheral blood. The intellectual developmental disorder, X-linked, syndromic, Armfield type (MRXSA) is caused by missense variants in . Functional studies revealed the pathogenesis to be a spliceosomopathy that is characterized by atypical mRNA processing during development. In this study, we assessed the peripheral blood specimens in a cohort of individuals with MRXSA and detected a unique and highly specific DNA methylation episignature associated with this disorder. We used this episignature to construct a support vector machine model capable of sensitive and specific identification of individuals with pathogenic variants in . This study contributes to the expanding number of genetic neurodevelopmental disorders with defined DNA methylation episignatures, provides an additional understanding of the associated molecular mechanisms, and further enhances our ability to diagnose patients with rare disorders.
越来越多的已知遗传神经发育障碍与独特的基因组 DNA 甲基化模式相关,这些模式被称为表观遗传特征,可在外周血中检测到。X 连锁、综合征性、阿姆菲尔德型智力发育障碍(MRXSA)是由. 中的错义变异引起的。功能研究表明,其发病机制是一种剪接体病,其特征是在发育过程中出现非典型的 mRNA 处理。在这项研究中,我们评估了 MRXSA 患者队列的外周血标本,并检测到与该疾病相关的独特且高度特异性的 DNA 甲基化表观遗传特征。我们使用该表观遗传特征构建了一个支持向量机模型,能够敏感和特异性地识别. 中存在致病性变异的个体。这项研究有助于增加具有明确 DNA 甲基化表观遗传特征的遗传神经发育障碍的数量,提供了对相关分子机制的进一步理解,并进一步提高了我们诊断罕见疾病患者的能力。